T.D. Le et al. / Journal of Organometallic Chemistry 694 (2009) 229–236
235
received. [Cp2ZrHCl]n was prepared following the procedure re-
ported by Buchwald et al. [15]. Infrared spectra were performed
in solution (KBr windows) on a Perkin–Elmer GX 2000 spectrome-
ter. Mass spectra were recorded on a TSQ7000 Thermo Electron (EI)
and on a Q Trap (ES–MS) mass spectrometer. Melting points were
obtained using an Electrothermal Digital Melting Point apparatus
and are uncorrected. Elemental analyses were carried out by the
‘‘Service d’ Analyse du Laboratoire de Chimie de Coordination” in
Toulouse.
(5 mL). The mixture was stirred for 5 min. The solvent was re-
moved by oil pump vacuum to give 3a in quasi quantitative yield
as a white residue (0.256 g, 0.480 mmol). Compound 3a was char-
acterized by NMR without any further treatment. 31P NMR
1
(81 MHz, CDCl3): [d/ppm] 31.7 (d, JPP = 282.5 Hz, N–P–P), ꢀ17.6
1
(d, JPP = 282.5 Hz, N–P–P). 1H NMR (200 MHz, CDCl3): [d/ppm]
3
7.58–7.03 (m, 21H, HPh and HC@N), 4.37 (sept, 1H, JHH = 6.8 Hz,
3
NCHCH3), 3.54 (sept, 1H, JHH = 6.7 Hz, NCHCH3), 1.12 (d, 6H,
3
3JHH = 6.8 Hz, NCHCH3), 0.92 (d, 6H, JHH = 6.7 Hz, NCHCH3). 13C
2
NMR (50 MHz, CDCl3): [d/ppm] 156.5 (d, JCP = 3.4 Hz, HC@N),
1
1
4.2. NMR experiments
135,1 (d, JCP = 7.0 Hz, i-PCPh), 134.7 (d, JCP = 10.4 Hz, i-PCPh),
134,5 (s, CHPh), 134.2(s, CHPh), 131.9 (d, JCP = 8.8 Hz, CHPh), 131.3
(s, CHPh), 129.7 (d, JCP = 11.8 Hz, CHPh), 129.3 (d, JCP = 7.3 Hz, CHPh),
50.1 (s, NCHCH3), 47.8 (s, NCHCH3), 23.1 (s, NCHCH3), 19.3 (s,
NCHCH3). 15N NMR (51 MHz, [toluene-d8]): [d/ppm] ꢀ210.0
(NiPr2), ꢀ244.0 (1JNP = 51.0 Hz, C@N–P).
1H, 1H–{31P}, 31P–{1H}, 13C–{1H} and 13C–{1H, 31P} NMR spectra
were recorded on a Bruker AV500, AV 400, and AV 300 spectrom-
eters equipped with a 5 mm triple resonance inverse probe with
dedicated 31P channel. All chemical shifts for 1H and 13C are rela-
tive to TMS using residual peak of the solvent as a secondary stan-
dard. 31P chemical shifts were referenced to an external 85% H3PO4
sample. The 15N resonances were referenced to neat CH3NO2. Tem-
perature calibration was determined using a methanol chemical
shift thermometer. All the 1H and 13C signals were assigned on
the basis of chemical shifts, spin–spin coupling constants, splitting
patterns and signal intensities, and by using 2D 1H–1H COSY45,
1H–13C HSQC, 1H–13C HMBC, 1H–15N HMBC and 31P–15N HMQC-
{1H} with broadband or selective 31P decoupling when necessary.
All spectra were recorded at ambient probe temperature unless
stated otherwise. NMR simulations were run with WINDNMR-Pro
7.1.12 software [12].
Compound 3b: 31P NMR (81 MHz, CDCl3): [d/ppm] 55.5 (d,
1
1JPP = 281.8 Hz, N–P–P), ꢀ36.7 (d, JPP = 281.8 Hz, N–P–P). 1H NMR
3
(200 MHz, CDCl3): [d/ppm] 8.75 (d, 1H, JHP = 20.8 Hz, HC@N),
4.41 (sept, 1H, 3JHH = 6.8 Hz, NCHCH3), 3.99 (sept, 1H, 3JHH = 6.8 Hz,
NCHCH3), 3.52 (m, 2H, PCH2CH3), 2.47 (m, 2H, PCH2CH3), 1.97 (m,
2H, PCH2CH3), 1.76 (m, 2H, PCH2CH3), 1.14–1.42 (m, 24H, NCHCH3
et PCH2CH3). 13C NMR (50 MHz, CDCl3): [d/ppm] 160.2 (d,
2JCP = 2.5 Hz, HC@N), 50.7 (s, NCHCH3), 46.9 (s, NCHCH3), 22.9 (s,
NCHCH3), 19.8 (s, NCHCH3), 18.0 (dd, JC,P = 47,6 Hz, JCP = 8.0 Hz,
NPCH2CH3), 14.1 (dd, JCP = 17.2 Hz, JCP = 2.9 Hz, PPCH2CH3), 11.7
(dd, JCP = 17.0 Hz, JC.P = 9,8 Hz, PPCH2CH3), 11.7 (dd, JCP = 17.0 Hz,
JCP = 9.8 Hz, PPCH2CH3), 6,4 (dd, JCP = 5.5 Hz; JCP = 5.5 Hz;
NPCH2CH3).
4.3. Preparation of N-phosphino formamidines iPr2NC(H)@NPEt2 (1b)
Compound 3c: 31P NMR (81 MHz, CD2Cl2): [d/ppm] 59.0 (d,
1
1JPP = 340.9 Hz, N–P–P), ꢀ6.2 (d, JPP = 340.9 Hz, N–P–P). 1H NMR
3
Following the procedure described for 1a,c [8], 1b and 1d were
prepared after addition of a solution of iPr2NCN (7.814 mmol) in
CH2Cl2 (5 mL) to a suspension of [Cp2Zr(H)Cl]n (7.814 mmol) in
CH2Cl2 (15 mL) followed by Et2PCl and (iPr2N)2PCl respectively
(7.814 mmol) to give 1b in 85% yield (1.436 g, 6.642 mmol) and
(200 MHz, CD2Cl2): [d/ppm] 8.42 (d, 1H, JHP = 19.3 Hz, HC@N),
3
4.49 (sept, 1H, JHH = 6.8 Hz, NCHCH3), 3.02 (m, 2H, PCHCH3),
2.43 (m, 2H, PCHCH3), 1.09–1.37 (m, 36H, CHCH3). 13C NMR
2
(50 MHz, CD2Cl2): [d/ppm] 160.4 (d, JCP = 7.5 Hz, HC@N), 50.5 (s,
NCHCH3), 49.8 (s, NCHCH3), 47.1 (d, JCP = 4.5 Hz, PCHCH3), 46.8
(d, JCP = 3.3 Hz, PCHCH3), 27.6 (dd, JCP = 41.7 Hz, PCHCH3), 23.4 (s,
NCHCH3), 21.8 (dd, JCP = 21.4 Hz, JCP = 2.4 Hz, PCHCH3), 21.5 (d,
JCP = 2.8 Hz, PCHCH3), 21.5 (s, NCHCH3), 19.7 (d, JCP = 3.1 Hz,
PCHCH3), 15.5 (d, JCP = 2.0 Hz, PCHCH3).
1d in 90% yield (2.502 g, 6.989 mmol). 1b: IR (KBr, THF):
m
(C@N) = 1607 cmꢀ1 31P NMR (121 MHz, C6D6): [d/ppm] 91.0 (s).
.
3
1H NMR (300 MHz, CD2Cl2): [d/ppm] 7.95 (d, 1H, JHP = 19.1 Hz,
HC@N), 4.56 (m, 1H, NCHCH3), 3.52 (m, 1H, NCHCH3), 1.42 (m,
3
4H, PCH2CH3), 1.35 (d, 6H, JHH = 6.8 Hz, NCHCH3), 1,32 (d, 6H,
Compound 3d: 31P NMR (202 MHz, CD2Cl2): [d/ppm] 50.5 (d,
3
3
1
3JHH = 6.7 Hz, NCHCH3), 0.99 (td, 6H, JHP = 14.8 Hz, JHH = 7.5 Hz,
PCH2CH3). 13C NMR (75 MHz, CD2Cl2): [d/ppm] 157.1 (d,
2JCP = 47.4 Hz, HC@N), 50.3 (s, NCHCH3), 47.1 (s, NCHCH3), 23.2 (s,
1JPP = 279.5 Hz, PEt2), ꢀ27.2 (d, JPP = 279.5 Hz, PPh2). 1H NMR
3
(500 MHz, CD2Cl2): [d/ppm] 8.10 (d, 1H, JHP = 20.6 Hz, HC@N),
3
7.72 ꢀ7.49 (m, 10H, HPh), 4.36 (sept, 1H, JHH = 6.8 Hz, NCHCH3),
2
3
3
NCHCH3), 19.7 (s, NCHCH3), 25.3 (d, JCP = 8.8 Hz, PCH2CH3), 9,0
3.79 (sept, 1H, JHH = 6.8 Hz, NCHCH3), 2.43 (m, 4H, JHH = 7.8 Hz,
2
3
(d, JCP = 13.5 Hz, PCH2CH3). EI MS m/z (%): 216 [M+]. C11H25N2P:
PCH2CH3), 1.21 (d, 6H, JHH = 6.8 Hz, NCHCH3), 1.20 (d, 6H,
3
3
calcd. C 61.08, H 11.65, N 12.95; found C, 61.96, H 12.08, N 12.48.
3JHH = 6.8 Hz, NCHCH3), 1,19 (td, 6H, JHP = 18.3 Hz, JHH = 7.6 Hz,
Compound 1d: IR (KBr, THF):
m .
(C@N) = 1602 cmꢀ1 31P NMR
PCH2CH3). 13C NMR (126 MHz, CD2Cl2): [d/ppm] 159.0 (s, HC@N),
(121 MHz, C6D6): [d/ppm] 71.3 (s). 1H NMR (300 MHz, CD2Cl2):
135.0 (dd, JCP = 21.4 Hz, JCP = 6.5 Hz, o-CHPh), 131.1 (s large,
2
3
3
5
3
[d/ppm] 8.14 (d, 1H, JHP = 18.0 Hz, HC@N), 4.72 (m, 1H, NCHCH3),
4JCP < 1.0 Hz, JCP = 2.3 Hz, p-CHPh), 129.7 (dd, JCP = 8.2 Hz,
3
3
1
2
3.92 (d sept; 4H; JHH = 6.7 Hz; JHP = 10,4 Hz; PNCHCH3), 3.11 (m,
4JCP < 2.0 Hz, m-CHPh), 126.8 (dd, JCP = 14.8 Hz, JCP = 4.0 Hz,
3
1
2
1H, NCHCH3), 1.48 (d; 12H; JHH = 6.7 Hz; PNCHCH3), 1.44 (d;
i-PCPh), 18.1 (dd, JCP = 48.2 Hz, JCP = 10.0 Hz, PCH2CH3), 6,1 (dd,
3
3
12H; JHH = 6.7 Hz; PNCHCH3), 1.19 (m, 6H, NCHCH3), 0.97 (m,
2JCP = 5.9 Hz, JCP = 5.8 Hz, PCH2CH3). 15N NMR (51 MHz, [toluene-
6H, NCHCH3). 13C NMR (75 MHz, CD2Cl2): [d/ppm] 152.3 (d,
d8]): [d/ppm] ꢀ213.9 (d, JNP = 10.0 Hz, NiPr2), ꢀ237.7 (d,
3
2JCP = 65.4 Hz, HC@N), 46.3 (s, NCHCH3), 45.5 (d; JCP = 11,4 Hz;
1JNP = 50.5 Hz, C@N–P).
2
2
PNCHCH3), 44.5 (s, NCHCH3), 24.9 (d, JCP = 8.8 Hz, PNCHCH3),
Compound 3e: 31P NMR (202 MHz, CD2Cl2): [d/ppm] 52.4 (d,
JPP = 311.2 Hz, PiPr2), ꢀ31.5 (d, JPP = 311.2 Hz, PPh2). 1H NMR
3
24.7 (d, JCP = 5.6 Hz; PNCHCH3), 24.0 (s, NCHCH3), 20.5 (s,
NCHCH3). EI MS m/z (%): 358 [M+]. Anal. Calc. for C19H43N4P: C,
(500 MHz, CD2Cl2): [d/ppm] 7.50 (d, 1H, JHP = 18.8 Hz, HC@N),
3
3
63.65; H, 12.09; N, 15.63. Found: C, 63.87; H, 12.23; N, 15.32%.
7.80–7.20 (m, 10H, HPh), 4.51 (sept, 1H, JHH = 6.8 Hz, NCHCH3),
3
3.63 (sept, 1H, JHH = 6.8 Hz, NCHCH3), 2.89 (sept d, 2H,
2
3
4.4. Representative experimental procedure for the preparation of P–P
homoatomic phosphinophosphonium formamidines [iPr2N–C(H)@N–
PR2–PR2]Cl (3a–e)
3JHH = 7.2 Hz, JHP = 12.6 Hz, PCHCH3), 1.32 (dd, 6H, JHH = 7.2 Hz,
3JHP = 17.3 Hz, PCHCH3), 1.30 (d, 6H, JHH = 6.8 Hz, NCHCH3), 1.24
3
3
3
(dd, 6H, JHH = 7.2 Hz, JHP = 16.8 Hz, PCHCH3), 1.14 (d, 6H,
3JHH = 6.8 Hz, NCHCH3). 13C NMR (126 MHz, CD2Cl2): [d/ppm]
157.7 (s, HC@N), 136.0–126.4 (broad resonances), 50.1 (s,
A Schlenk flask was charged with iPr2N–C(H)@N–PPh2 (1a,
0.151 g, 0.480 mmol), Ph2PCl (2a, 0.106 g, 0.480 mmol) and CH2Cl2
1
NCHCH3), 47.0 (s, NCHCH3), 27.1 (d, JCP = 43.7 Hz, PCHCH3), 22.9